BXTA NANOTHERAPY LTD

Active Slough

Specialists medical practice activities

4 employees website.com
Life sciences and medical technology Specialists medical practice activities
B

BXTA NANOTHERAPY LTD

Specialists medical practice activities

Founded 9 Dec 2022 Active Slough, United Kingdom 4 employees website.com
Life sciences and medical technology Specialists medical practice activities
Accounts Submitted 6 Feb 2026 Next due 31 Mar 2027 9 months remaining
Confirmation Submitted 20 Dec 2025 Next due 22 Dec 2026 6 months remaining
Net assets £335K £32K 2025 year on year
Total assets £575K £186K 2025 year on year
Total Liabilities £240K £154K 2025 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

The Coach House Grenville Court Britwell Road, Burnham Slough SL1 8DF United Kingdom

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for BXTA NANOTHERAPY LTD (14533667), an active life sciences and medical technology company based in Slough, United Kingdom. Incorporated 9 Dec 2022. Specialists medical practice activities. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jul → 30 Jun 2025
Type small
Next accounts 30 Jun 2026
Due by 31 Mar 2027 9 months remaining

Net Assets, Total Assets & Total Liabilities (2023–2025)

Cash in Bank

£80.72k

Decreased by £252.14k (-76%)

Net Assets

£335.09k

Decreased by £32.34k (-9%)

Total Liabilities

£239.88k

Decreased by £154.03k (-39%)

Turnover

N/A

Employees

4

Debt Ratio

42%

Decreased by 10 (-19%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
30 Jun Year End
2024
30 Jun Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

13 Allotments 1,723 Shares £1.81m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
27 Feb 202691£100k£1k
29 Oct 2025137£150k£1k
28 Jul 202591£100k£1k
29 Apr 202591£100k£1k
31 Oct 2024190£208k£1k

Officers

Officers

3 active
Status
David MooreDirectorBritishNorthern Ireland6230 Jan 2023Active
Guy PettigrewSecretaryUnknownUnknown9 Dec 2022Active
Saheed RashidDirectorBritishEngland649 Dec 2022Active

Shareholders

Shareholders (2)

Bxtaccelyon Limited
73.7%
1,204
Qubis Ltd
26.3%
429

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Bxtaccelyon Limited

United Kingdom

Active
Notified 9 Dec 2022
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

ELYSIAN CAPITAL LLP united kingdom
SEED NEWCO LIMITED united kingdom
SEED BIDCO LIMITED united kingdom
BXTACCELYON LIMITED united kingdom
BXTA NANOTHERAPY LTD Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
1 Jun 2026CapitalAllotment of shares (GBP 1,815) on 31 May 2026
20 Apr 2026CapitalAllotment of shares (GBP 1,724) on 27 Feb 2026
6 Feb 2026AccountsAnnual accounts made up to 30 Jun 2025
8 Jan 2026OfficersTermination of David Moore as director on 31 Dec 2025
20 Dec 2025Confirmation StatementConfirmation statement made on 8 Dec 2025 with updates
1 Jun 2026 Capital

Allotment of shares (GBP 1,815) on 31 May 2026

20 Apr 2026 Capital

Allotment of shares (GBP 1,724) on 27 Feb 2026

6 Feb 2026 Accounts

Annual accounts made up to 30 Jun 2025

8 Jan 2026 Officers

Termination of David Moore as director on 31 Dec 2025

20 Dec 2025 Confirmation Statement

Confirmation statement made on 8 Dec 2025 with updates

Recent Activity

Latest Activity

Allotment of shares (GBP 1,815) on 31 May 2026

1 weeks ago on 1 Jun 2026

Allotment of shares (GBP 1,724) on 27 Feb 2026

1 months ago on 20 Apr 2026

Annual accounts made up to 30 Jun 2025

4 months ago on 6 Feb 2026

Termination of David Moore as director on 31 Dec 2025

5 months ago on 8 Jan 2026

Confirmation statement made on 8 Dec 2025 with updates

5 months ago on 20 Dec 2025